FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200469664> ?p ?o ?g. }

• W4200469664 endingPage "781" @default.
• W4200469664 startingPage "769" @default.
• W4200469664 abstract "As a research hotspot, immune checkpoint inhibitors (ICIs) is often combined with other therapeutics in order to exert better clinical efficacy. To date, extensive laboratory and clinical investigations into the combination of ICIs and chemotherapy have been carried out, demonstrating augmented effectiveness and broad application prospects in anti-tumor therapy. However, the administration of these two treatment modalities is usually randomized or fixed to a given chronological order. Nevertheless, the pharmacological effect of drug is closely related to its exposure behavior in vivo, which may consequently affect the synergistic outcomes of a combined therapy. In this study, we prepared a lipid nanoparticle encapsulating docetaxel (DTX-VNS), and associated it with the immune checkpoint inhibitor anti-PD-1 antibody (αPD-1) for the treatment of malignant tumors. To identify the optimum timing and sequencing for chemotherapy and immunotherapy, we designed three administration regimes, including the simultaneous delivery of DTX-VNS and αPD-1(DTX-VNS@αPD-1), DTX-VNS delivery before (DTX-VNS plus αPD-1) or post (αPD-1 plus DTX-VNS) PD-1 blockade with an interval of two days. Analysis from mass spectrometry, multi-factor detection and other techniques indicated that DTX-VNS plus αPD-1 initiated a powerful anti-tumor response in multiple tumor models, contributing to a remarkably reshaped tumor microenvironment landscape, which may attribute to the maximum therapeutic additive effects arise from a concomitant exposure of DTX-VNS and αPD-1 at the tumor site. By profiling the exposure kinetics of nanoparticles and αPD-1 in vivo, we defined the administration schedule with utmost therapeutic benefits, which may provide a valuable clinical reference for the rational administration of immunochemotherapy." @default.
• W4200469664 created "2021-12-31" @default.
• W4200469664 creator A5009324255 @default.
• W4200469664 creator A5016827379 @default.
• W4200469664 creator A5020940972 @default.
• W4200469664 creator A5022443764 @default.
• W4200469664 creator A5029198852 @default.
• W4200469664 creator A5029265134 @default.
• W4200469664 creator A5033603327 @default.
• W4200469664 creator A5038379315 @default.
• W4200469664 creator A5041664650 @default.
• W4200469664 creator A5050802712 @default.
• W4200469664 creator A5051082981 @default.
• W4200469664 creator A5051584033 @default.
• W4200469664 creator A5066521589 @default.
• W4200469664 creator A5082372392 @default.
• W4200469664 creator A5090805708 @default.
• W4200469664 date "2022-01-01" @default.
• W4200469664 modified "2023-10-13" @default.
• W4200469664 title "Rational administration sequencing of immunochemotherapy elicits powerful anti-tumor effect" @default.
• W4200469664 cites W1547450219 @default.
• W4200469664 cites W1548403485 @default.
• W4200469664 cites W1977633435 @default.
• W4200469664 cites W1980137951 @default.
• W4200469664 cites W1981291019 @default.
• W4200469664 cites W1986342542 @default.
• W4200469664 cites W1989976028 @default.
• W4200469664 cites W1999999047 @default.
• W4200469664 cites W2002548381 @default.
• W4200469664 cites W2003870922 @default.
• W4200469664 cites W2008534009 @default.
• W4200469664 cites W2009501393 @default.
• W4200469664 cites W2049491375 @default.
• W4200469664 cites W2053967595 @default.
• W4200469664 cites W2061187116 @default.
• W4200469664 cites W2066671159 @default.
• W4200469664 cites W2070855360 @default.
• W4200469664 cites W2081374651 @default.
• W4200469664 cites W2104347254 @default.
• W4200469664 cites W2106511557 @default.
• W4200469664 cites W2106511606 @default.
• W4200469664 cites W2107484016 @default.
• W4200469664 cites W2127182674 @default.
• W4200469664 cites W2134571000 @default.
• W4200469664 cites W2138397823 @default.
• W4200469664 cites W2140948050 @default.
• W4200469664 cites W2143772132 @default.
• W4200469664 cites W2148226248 @default.
• W4200469664 cites W2152897456 @default.
• W4200469664 cites W2162166699 @default.
• W4200469664 cites W2198093519 @default.
• W4200469664 cites W2214516135 @default.
• W4200469664 cites W2261563054 @default.
• W4200469664 cites W2340636398 @default.
• W4200469664 cites W2411767313 @default.
• W4200469664 cites W2415125269 @default.
• W4200469664 cites W2511881100 @default.
• W4200469664 cites W2561926137 @default.
• W4200469664 cites W2590692536 @default.
• W4200469664 cites W2593371437 @default.
• W4200469664 cites W2616155686 @default.
• W4200469664 cites W2726313690 @default.
• W4200469664 cites W2747207966 @default.
• W4200469664 cites W2796582438 @default.
• W4200469664 cites W2886140684 @default.
• W4200469664 cites W2886142748 @default.
• W4200469664 cites W2890100090 @default.
• W4200469664 cites W2892640821 @default.
• W4200469664 cites W2912044537 @default.
• W4200469664 cites W2925030036 @default.
• W4200469664 cites W2943432615 @default.
• W4200469664 cites W2944687997 @default.
• W4200469664 cites W2946386783 @default.
• W4200469664 cites W2997384004 @default.
• W4200469664 cites W2999417355 @default.
• W4200469664 cites W3015116944 @default.
• W4200469664 cites W3019468486 @default.
• W4200469664 cites W3025003676 @default.
• W4200469664 cites W3026266297 @default.
• W4200469664 cites W3027648247 @default.
• W4200469664 cites W3105802462 @default.
• W4200469664 cites W3111745735 @default.
• W4200469664 cites W3117356512 @default.
• W4200469664 doi "https://doi.org/10.1016/j.jconrel.2021.12.022" @default.
• W4200469664 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34952044" @default.
• W4200469664 hasPublicationYear "2022" @default.
• W4200469664 type Work @default.
• W4200469664 citedByCount "8" @default.
• W4200469664 countsByYear W42004696642022 @default.
• W4200469664 countsByYear W42004696642023 @default.
• W4200469664 crossrefType "journal-article" @default.
• W4200469664 hasAuthorship W4200469664A5009324255 @default.
• W4200469664 hasAuthorship W4200469664A5016827379 @default.
• W4200469664 hasAuthorship W4200469664A5020940972 @default.
• W4200469664 hasAuthorship W4200469664A5022443764 @default.
• W4200469664 hasAuthorship W4200469664A5029198852 @default.
• W4200469664 hasAuthorship W4200469664A5029265134 @default.
• W4200469664 hasAuthorship W4200469664A5033603327 @default.

• next